1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Par Drugs and Chemicals Limited

Par Drugs and Chemicals Limited

PAR.NS
Par Drugs and Chemicals LimitedIN flagNational Stock Exchange of India
90.49
INR
-0.21
- -
1.11BMarket Cap

Total Valuation

Par Drugs and Chemicals Limited carries a market capitalization of 1.11B, placing it among publicly traded companies globally. Its enterprise value stands at 549.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.11B
Enterprise Value549.84M

Share Statistics

Par Drugs and Chemicals Limited currently has 12.30M shares outstanding.

Shares Outstanding12.30M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Par Drugs and Chemicals Limited trades at a trailing price-to-earnings ratio of 7.39. The price-to-sales ratio is 0.93, and the price-to-book ratio stands at 7.87.

PE Ratio7.39
PS Ratio0.93
PB Ratio7.87
P/TBV Ratio0.86
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Par Drugs and Chemicals Limited trades at an EV/EBITDA multiple of 4.09 and an EV/FCF ratio of 569.64. The EV/Sales ratio of 0.53 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.09 provides insight into valuation relative to core operating earnings.

EV / Sales0.53
EV / EBITDA4.09
EV / EBIT4.09
EV / FCF569.64

Financial Position

Par Drugs and Chemicals Limited maintains a current ratio of 4.68, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities.

Current Ratio4.68
Quick Ratio3.04
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage105.40

Financial Efficiency

Par Drugs and Chemicals Limited posts a return on equity of 26.09 and a return on invested capital of 9.44.

Return on Equity (ROE)26.09
Return on Assets (ROA)10.55
Return on Invested Capital (ROIC)9.44
Return on Capital Employed (ROCE)26.28
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover7.56

Taxes

Over the trailing twelve months, Par Drugs and Chemicals Limited has paid 41.93M in income taxes, reflecting an effective tax rate of 24.23.

Income Tax41.93M
Effective Tax Rate24.23

Stock Price Statistics

Par Drugs and Chemicals Limited's stock has declined approximately -4.99738% over the past 52 weeks. The 50-day moving average sits at 90.25, while the 200-day moving average is 94.37.

Beta (5Y)N/A
52-Week Price Change-4.99738%
50-Day Moving Average90.25
200-Day Moving Average94.37
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Par Drugs and Chemicals Limited generated 1.04B in revenue and converted that into 131.09M in net income, yielding earnings per share of 10.64. EBITDA reached 134.28M, while operating income came in at 134.28M.

Revenue1.04B
Gross Profit602.94M
Operating Income134.28M
Pretax Income173.02M
Net Income131.09M
EBITDA134.28M
EBIT134.28M
Earnings Per Share (EPS)10.64

Balance Sheet

Total book value stands at 123.05M, with working capital of 505.82M providing operational flexibility.

Cash & Cash Equivalents418.43M
Total DebtN/A
Net Debt-418.43M
Equity (Book Value)123.05M
Book Value Per Share9.99
Working Capital505.82M

Margins

Par Drugs and Chemicals Limited operates with a gross margin of 58.17, reflecting its pricing power and cost economics. The operating margin of 12.95 and net profit margin of 12.65 provide insight into operational efficiency.

Gross Margin58.17
Operating Margin12.95
Pretax Margin16.69
Profit Margin12.65
EBITDA Margin12.95

Stock Splits

Par Drugs and Chemicals Limited's most recent stock split took place on April 27, 2021 with a 1:2 split ratio.

Last Split Date4/27/2021
Split Ratio1:2

Scores

Par Drugs and Chemicals Limited posts an Altman Z-Score of 4.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.99